Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Thorac Surg ; 106(5): 1504-1511, 2018 11.
Article in English | MEDLINE | ID: mdl-30086278

ABSTRACT

BACKGROUND: Several gray areas and controversies exist concerning the management of pulmonary ground-glass opacities (GGOs), and there is a lack of consensus among clinicians on this topic. One of the main aims of the Italian Society of Thoracic Surgery is to promote education and research, so we decided to perform a survey on this topic to estimate current trends in practice in a large sample of thoracic surgeons. METHODS: A total of 160 thoracic surgeons responded, namely, completed our questionnaire (response rate, 53%; 160 of 302). The survey was composed of 36 questions divided into six subsections: (1) demographic characteristics of the respondents; (2) terminology and taxonomy; (3) radiologic and radiometabolic evaluation; (4) diagnostic approach and indications for surgery; (5) surgical management; and (6) radiologic surveillance. RESULTS: We observed some divergence of opinion regarding the definition of mixed GGOs, the role of 18F fluorodeoxyglucose positron emission tomography and computed tomography scans, indications for nonsurgical biopsy, intraoperative techniques for localizing GGOs, indications for surgery, extension of lung resection and lymph node dissection according to the radiologic scenario, use of intraoperative frozen section analysis, and radiologic surveillance of pure GGOs. CONCLUSIONS: This topic warrants more investigation in the future. An upcoming consensus conference of Italian Society of Thoracic Surgery experts (also open to experts in other specialties) could provide updated indications for GGO management based on the literature, expert opinions, and the results of the present survey.


Subject(s)
Lung Neoplasms/diagnostic imaging , Outcome Assessment, Health Care , Positron-Emission Tomography/standards , Surveys and Questionnaires , Tomography, X-Ray Computed/standards , Attitude of Health Personnel , Female , Health Care Surveys , Humans , Italy , Lung/diagnostic imaging , Lung/pathology , Lung Neoplasms/pathology , Lung Neoplasms/surgery , Male , Positron-Emission Tomography/trends , Practice Patterns, Physicians'/standards , Practice Patterns, Physicians'/trends , Risk Assessment , Societies, Medical , Surgeons , Thoracic Surgery/standards , Thoracic Surgery/trends , Tomography, X-Ray Computed/trends
2.
PLoS One ; 12(10): e0185610, 2017.
Article in English | MEDLINE | ID: mdl-29016628

ABSTRACT

The incidence of hepatocellular carcinoma (HCC), the most common primary liver cancer, is increasing in the US and tripled during the past two decades. The reasons for such phenomenon remain poorly understood. Texas is among continental states with the highest incidence of liver cancer with an annual increment of 5.7%. Established risk factors for HCC include Hepatitis B and C (HBV, HCV) viral infection, alcohol, tobacco and suspected risk factors include obesity and diabetes. While distribution of these risk factors in the state of Texas is similar to the national data and homogeneous, the incidence of HCC in this state is exceptionally higher than the national average and appears to be dishomogeneous in various areas of the state suggesting that other non-recognized risk factors might play a role. No population-based studies are currently available investigating the effect of exposure to Hazardous Air Pollutants (HAPs) as a contributing risk factor for liver cancer. Incidence rate of liver cancer in Texas by counties for the time period between 2002 and 2012 was obtained from the Texas Cancer Registry (TCR). Through Principal Component Analysis (PCA) a subgroup of pollutants, explaining almost all the dataset variability, were identified and used to cluster Texas counties. The analysis generated 4 clusters showing liver cancer rate either higher or lower than national average in association with either high or low levels of HAPs emission in the environment. The study shows that the selected relevant HAPs, 10 among 253 analyzed, produce a significant correlation (P = 0.01-0.05) and some of these have been previously identified as carcinogens. An association between the increased production and consequent exposure to these HAPs and a higher presence of liver cancer in certain counties is suggested. This study provides a new insight on this complex multifactorial disease suggesting that environmental substances might play a role in the etiology of this cancer.


Subject(s)
Air Pollutants/adverse effects , Carcinoma, Hepatocellular/epidemiology , Environmental Exposure/adverse effects , Liver Neoplasms/epidemiology , Organic Chemicals/adverse effects , Carcinoma, Hepatocellular/diagnosis , Carcinoma, Hepatocellular/etiology , Carcinoma, Hepatocellular/pathology , Environmental Monitoring , Humans , Incidence , Liver Neoplasms/diagnosis , Liver Neoplasms/etiology , Liver Neoplasms/pathology , Principal Component Analysis , Risk Factors , Texas/epidemiology
3.
PLoS One ; 11(4): e0153613, 2016.
Article in English | MEDLINE | ID: mdl-27074018

ABSTRACT

Isolation of hepatocytes from cirrhotic human livers and subsequent primary culture are important new tools for laboratory research and cell-based therapeutics in the study of hepatocellular carcinoma (HCC). Using such techniques, we have previously identified different subpopulations of human hepatocytes and among them one is showing a progressive transformation of hepatocytes in HCC-like cells. We have hypothesized that increasing the distance from the neoplastic lesion might affect hepatocyte function and transformation capacity. However, limited information is available in comparing the growth and proliferation of human hepatocytes obtained from different areas of the same cirrhotic liver in relation to their distance from the HCC lesion. In this study, hepatocytes from 10 patients with cirrhosis and HCC undergoing surgical resections from specimens obtained at a proximal (CP) and distal (CD) distance from the HCC lesion were isolated and placed in primary culture. CP hepatocytes (CP-Hep) were isolated between 1 to 3 cm (leaving at least 1cm margin to avoid cancer cells and/or satellite lesions), while CD hepatocytes (CD-Hep) were isolated from more than 5 cm or from the contralateral-lobe. A statistical model was built to analyze the proliferation rates of these cells and we evaluated expression of HCC markers (Glypican-3 (GPC3), αSmooth Muscle Actin (α-SMA) and PCNA). We observed a significant difference in proliferation and in-vitro growth showing that CP-Hep had a proliferation pattern and rate significantly different than CD-Hep. Based on these data, this model can provide information to predict growth of human hepatocytes in primary culture in relation to their pre-cancerous state with significant differences in the HCC markers expression. This model provides an important innovative tool for in-vitro analysis of HCC.


Subject(s)
Carcinoma, Hepatocellular/pathology , Cell Proliferation , Hepatocytes/pathology , Liver Cirrhosis/pathology , Liver Neoplasms/pathology , Aged , Female , Humans , Male , Middle Aged , Tumor Cells, Cultured
4.
Cancer ; 121(18): 3230-9, 2015 Sep 15.
Article in English | MEDLINE | ID: mdl-26060090

ABSTRACT

BACKGROUND: Heat shock protein 60 (Hsp60) is a chaperonin involved in tumorigenesis, but its participation in tumor development and progression is not well understood and its value as a tumor biomarker has not been fully elucidated. In the current study, the authors presented evidence supporting the theory that Hsp60 has potential as a biomarker as well as a therapeutic target in patients with large bowel cancer. METHODS: The authors studied a population of 97 subjects, including patients and controls. Immunomorphology, Western blot analysis, and quantitative real-time polymerase chain reaction were performed on tissue specimens. Exosomes were isolated from blood and characterized by electron microscopy, biochemical tests, and Western blot analysis. RESULTS: Hsp60 was found to be increased in cancerous tissue, in which it was localized in the tumor cell plasma membrane, and in the interstitium associated with cells of the immune system, in which it was associated with exosomes liberated by tumor cells and, as such, circulated in the blood. An interesting finding was that these parameters returned to normal shortly after tumor removal. CONCLUSIONS: The data from the current study suggested that Hsp60 is a good candidate for theranostics applied to patients with large bowel carcinoma and encourage similar research among patients with other tumors in which Hsp60 has been implicated.


Subject(s)
Adenocarcinoma/pathology , Chaperonin 60/metabolism , Colonic Neoplasms/pathology , Exosomes/metabolism , Mitochondrial Proteins/metabolism , Adenocarcinoma/metabolism , Adenocarcinoma/surgery , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Blotting, Western , Chaperonin 60/analysis , Colonic Neoplasms/metabolism , Colonic Neoplasms/surgery , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunohistochemistry , Male , Middle Aged , Mitochondrial Proteins/analysis , Real-Time Polymerase Chain Reaction
5.
Anticancer Res ; 27(6B): 4039-46, 2007.
Article in English | MEDLINE | ID: mdl-18225568

ABSTRACT

BACKGROUND: The role of mitochondrial DNA (mtDNA) in anthracycline-induced apoptosis is controversial. Sabarubicin accumulates in the mitochondria of A2780 human ovarian tumor cells. The effects of this new anthracycline on the structure and the functionality of mtDNA, as well as on the apoptosis of mtDNA-depleted cells have been investigated. MATERIALS AND METHODS: Sabarubicin-induced mtDNA cleavage was detected by Southern blotting and mitochondrial mRNA expression was analyzed by real-time PCR. Apoptosis was studied in mtDNA-depleted (theta0) and parental (theta+) A2780 cells detecting nuclear DNA fragmentation using ELISA and cytofluorimetrically using Annexin V/PI staining. Mitochondrial membrane potential was studied using the cyanine dye JC-1. RESULTS: Sabarubicin induced mtDNA cleavage in the A2780 cells, but this damage did not affect mitochondrial mRNA expression. Apoptosis was induced by sabarubicin in theta0 as well as in theta+ cells. CONCLUSION: The results showed that mtDNA did not influence anthracycline-induced apoptosis in A2780 cells.


Subject(s)
Antibiotics, Antineoplastic/pharmacology , Apoptosis/drug effects , DNA, Mitochondrial/metabolism , Disaccharides/pharmacology , Doxorubicin/analogs & derivatives , Ovarian Neoplasms/drug therapy , Antibiotics, Antineoplastic/pharmacokinetics , Apoptosis/genetics , Blotting, Southern , Cell Line, Tumor , Disaccharides/pharmacokinetics , Doxorubicin/pharmacokinetics , Doxorubicin/pharmacology , Female , Gene Expression/drug effects , Humans , Membrane Potential, Mitochondrial/drug effects , Mitochondria/drug effects , Mitochondria/metabolism , Ovarian Neoplasms/genetics , Ovarian Neoplasms/pathology , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...